AddLife

AddLife Deferred Tax Liabilities

The Deferred Tax Liabilities of AddLife (ALIF B.ST) as of Oct 9, 2026 is 374.00 M SEK. In the previous year, Deferred Tax Liabilities was 415.00 M SEK — a change of -9.88% (lower).

Deferred Tax Liabilities

374.00 MSEK

YoY

-9.88%

Last updated:

Deferred Tax Liabilities of AddLife is 2024 374.00 M SEK. Deferred Tax Liabilities of AddLife was 2023 415.00 M SEK. It decreases by -9.88% lower compared to the previous year.

The AddLife Deferred Tax Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Deferred Tax Liabilities
Date
Deferred Tax Liabilities
Jan 1, 2016
40.20 M SEK
Jan 1, 2017
76.00 M SEK
Jan 1, 2019
127.30 M SEK
Jan 1, 2020
161.50 M SEK
Jan 1, 2021
489.40 M SEK
Jan 1, 2022
459.00 M SEK
Jan 1, 2023
415.00 M SEK
Jan 1, 2024
374.00 M SEK
The AddLife Deferred Tax Liabilities history
YEARDeferred Tax LiabilitiesYoY
374.00 MSEK-9.88%
415.00 MSEK-9.59%
459.00 MSEK-6.21%
489.40 MSEK+203.03%
161.50 MSEK+26.87%
127.30 MSEK+67.50%
76.00 MSEK+89.05%
40.20 MSEK—
Access this data via the Eulerpool API
Get Free API Key

AddLife Stock analysis

What does AddLife do? AddLife AB is a publicly listed company from Sweden that operates in the medical technology and healthcare industry. The company was founded in 2015 through the merger of several companies. AddLife AB is headquartered in Stockholm and currently employs over 2,000 employees in Sweden, Denmark, Finland, Norway, and Germany. The business model of AddLife AB is based on the acquisition and integration of leading technology companies in the healthcare industry. These companies are integrated into the AddLife Group and supported. Through collaboration within the group, synergies can be leveraged and competitiveness can be increased. AddLife offers its customers a wide range of products and services in various sectors. The company operates in the areas of diagnostics & life science, medical technology, and laboratory products. Diagnostics & life science includes products in the field of in vitro diagnostics, food analysis, nuclear medicine, and animal health. AddLife offers a wide range of products and services that are used in disease research and diagnostics. In the medical technology sector, AddLife AB offers products used by the medical technology industry, hospitals, and healthcare facilities. The product range includes surgical instruments, neurosurgery, orthopedics, and cardiology. AddLife is also involved in the project development of complete solutions for customers in this field. In the laboratory products sector, AddLife AB offers products and services for laboratories and research facilities. The product range includes laboratory equipment, laboratory consumables, and life science products. AddLife also offers services in the maintenance and validation of laboratory equipment. AddLife AB also has its own product brand, Labkotec, which manufactures products for fluid control and environmental and process condition monitoring. Labkotec operates internationally and offers products for various industries, such as the food and beverage industry, energy and environmental industry, steel industry, as well as the chemical and pharmaceutical industry. AddLife is known for its innovative products and solutions and works closely with customers to find individual solutions for their needs. The company sees itself as a provider of solutions and services for the medical industry and aims to improve the health and well-being of people through its products and services. AddLife is one of the most popular companies on Eulerpool.

Frequently Asked Questions about AddLife stock

Deferred Tax Liabilities of AddLife is 374.00 M SEK in 2024.

Deferred Tax Liabilities of AddLife changed from 415.00 M SEK to 374.00 M SEK, representing a -9.88% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Deferred Tax Liabilities AddLife since 2006 – with annual values, charts, and detailed analysis.

Deferred tax liabilities arise from temporary differences between accounting and tax treatments. They represent taxes owed in the future on income already recognized.

Deferred Tax Liabilities's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Deferred Tax Liabilities's AddLife historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — AddLife

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — AddLife